David Letterman is back with Season 6 of My Next Guest Needs No Introduction on Netflix. The former late-night host recently sat down with Jay Kelly star Adam Sandler for a special episode. That ...

Researchers at Google Quantum AI have used their Willow quantum computer to help interpret data from Nuclear Magnetic Resonance (NMR) spectroscopy, a mainstay of chemistry and biology research. The ...

HOBOKEN, N.J. and CALGARY, AB—Wiley, a global leader in authoritative content and research intelligence, announced new file support in their KnowItAll 2026 software release for raw NMR files from ...

This gathering brings together early career researchers and established scientists in the field of NMR spectroscopy, providing a supportive environment for sharing cutting-edge research. This year's ...

First successful customer installation of novel dissolution d-DNP Polarizer at UCSF SAN FRANCISCO--(BUSINESS WIRE)-- Bruker Corporation (BRKR) today announced the introduction of its groundbreaking ...

SAN FRANCISCO--(BUSINESS WIRE)-- Bruker Corporation today announced the introduction of its groundbreaking dissolution Dynamic Nuclear Polarization (d-DNP) Polarizer at the 2025 Hyperpolarized ...

A compelling introduction is crucial for making a strong first impression in your cover letter. Personalize your cover letter by addressing the hiring manager by name and tailoring your opening to ...

The composition of complex mixtures of molecules can be determined using NMR spectroscopy. Each of the thin glass tubes is filled with an extract of sea water that contains a few milligrams of ...

Solid-state nuclear magnetic resonance (NMR) spectroscopy is a quickly improving approach that broadens the spectrum of samples and use cases that may be studied via contemporary NMR spectroscopy. In ...

siRNA therapies show promise for treating diseases like cancer and genetic disorders, but their effectiveness depends on proper delivery. A recent study found that the method of mixing siRNA with ...

Using a computational biomarker, the companies say they can identify which patients would derive significant clinical benefit from their experimental antibody-drug conjugate. AstraZeneca and Roche are ...